Huang Lv-Yin, Pan Min, Han Jin, Zhen Li, Yang Xin, Li Dong-Zhi
a Prenatal Diagnostic Center , Guangzhou Women and Children's Medical Center affiliated to Guangzhou Medical University , Guangzhou , Guangdong , China.
J Obstet Gynaecol. 2018 May;38(4):498-501. doi: 10.1080/01443615.2017.1391755. Epub 2018 Feb 12.
The aim of this study was to evaluate which chromosomal abnormalities in our cohort of foetuses with increased nuchal translucency (NT) in the first trimester of pregnancy could be detected by cell free (cf)DNA screening as well. There were 775 singleton pregnancies referred for cytogenetic testing due to an increased NT (≥3.0 mm). Chromosome aberrations were investigated using karyotyping or chromosomal microarray analysis (CMA). Karyotyping had been chosen for foetal cytogenetic testing by 446 patients, and CMA by 329 patients. Common aneuploidies (trisomies 21, 18, 13 and sex aneuploidies) were detected in 2.2% (99/446) and 1.8% (59/329) cases, respectively. In 329 with CMA testing, clinically significant copy number variations (CNVs) other than common aneuploidies were detected in 2.7% cases; among these, five had a pathogenic microscopic CNV, which could have been detected by karyotyping. There were four cases (1.2%) having a pathogenic submicroscopic CNV, which could have been missed by karyotyping. The total CMA detection rate (23.4%) was not statistically different from that (24.2%) by karyotyping (p > .05). The percentage of chromosomal aberrations, which cfDNA screening would miss in patients with increased NT in the first trimester, might be the same as in those with normal NT. Impact statement What is already known about this topic? First trimester NT is a powerful marker for screening for common aneuploidies. cfDNA screening is more accurate than any standard screening with NT. The need of NT in the era of prenatal screening using cfDNA is debated. What does this study add? An increased NT did not identify any additional aneuploidies that were detected by cfDNA screening. What are the implications of these findings for clinical practice and/or further research? The percentage of chromosomal aberrations which cfDNA screening would miss in patients with increased NT might be the same as in those with normal NT.
本研究的目的是评估在妊娠早期颈部透明带(NT)增厚的胎儿队列中,哪些染色体异常也可通过游离(cf)DNA筛查检测出来。共有775例单胎妊娠因NT增厚(≥3.0毫米)而被转诊进行细胞遗传学检测。采用核型分析或染色体微阵列分析(CMA)研究染色体畸变情况。446例患者选择了核型分析进行胎儿细胞遗传学检测,329例患者选择了CMA。常见非整倍体(21、18、13三体及性染色体非整倍体)分别在2.2%(99/446)和1.8%(59/329)的病例中被检测到。在329例行CMA检测的病例中,2.7%的病例检测到除常见非整倍体外具有临床意义的拷贝数变异(CNV);其中,5例具有致病性微观CNV,核型分析本可检测到。有4例(1.2%)具有致病性亚微观CNV,核型分析可能会漏检。CMA的总检测率(23.4%)与核型分析的检测率(24.2%)无统计学差异(p>0.05)。在妊娠早期NT增厚的患者中,cfDNA筛查可能遗漏的染色体畸变百分比,可能与NT正常的患者相同。影响声明关于该主题已知的信息有哪些?妊娠早期NT是筛查常见非整倍体的有力标志物。cfDNA筛查比任何基于NT的标准筛查更准确。在使用cfDNA进行产前筛查的时代,NT的必要性存在争议。本研究补充了什么?NT增厚并未识别出cfDNA筛查检测到的任何额外非整倍体。这些发现对临床实践和/或进一步研究有何意义?在NT增厚的患者中,cfDNA筛查可能遗漏的染色体畸变百分比,可能与NT正常的患者相同。